Tumor inhibiting [1,2-bis(fluorophenyl)ethylenediamine]platinum(II) complexes. Part IV: Biological evaluation--in vivo studies on the P 388 leukemia.
Reile
H
H
Institut für Pharmazie, Lehrstuhl Pharmazeutische Chemie II, Universität Regensburg, FRG.
Spruss
T
T
Bernhardt
G
G
Müller
R
R
Gust
R
R
Schönenberger
H
H
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D007941:Leukemia P388 / Q000188:drug therapy*; D051379:Mice; D008815:Mice, Inbred Strains; D009944:Organoplatinum Compounds / Q000627:therapeutic use*; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; C064244:(1,2-bis(4-fluorophenyl)ethylenediamine)dichloroplatinum(II)